image
Adaptimmune Therapeutics plc ADAP
Healthcare - Biotechnology - NASDAQ - GB
Watchlist
$ 0.5866
-0.778 %
$ 150 M
Market Cap
-1.63
P/E
BALANCE SHEET
283 M ASSETS
-14.08%
Growth Rates
1Year -14.08%
3Years -14.44%
5Years 0.42%
7Years 2.70%
10Years 65.71%
243 M LIABILITIES
-1.59%
Growth Rates
1Year -1.59%
3Years 30.29%
5Years 52.11%
7Years 19.87%
10Years 50.92%
39.5 M EQUITY
-51.74%
Growth Rates
1Year -51.74%
3Years -51.26%
5Years -30.68%
7Years -18.55%
10Years 35.15%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Adaptimmune Therapeutics plc
image
Current Assets 208 M
Cash & Short-Term Investments 147 M
Receivables 46.9 M
Other Current Assets 13.7 M
Non-Current Assets 75.1 M
Long-Term Investments 0
PP&E 71.7 M
Other Non-Current Assets 3.36 M
Current Liabilities 72.8 M
Accounts Payable 8.13 M
Short-Term Debt 10.8 M
Other Current Liabilities 53.9 M
Non-Current Liabilities 170 M
Long-Term Debt 39.7 M
Other Non-Current Liabilities 131 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Jun-2015 Jun-2014 Jun-2013 Jun-2012
ASSETS
Cash & Cash Equivalents 144.0 108.0 149.9 56.9 50.4 68.4 84.0 158.8 229.1 51.3 0.2 3.0
Short Term Investments 2.9 96.6 219.6 311.3 39.1 136.8 124.2 22.7 55.3 0 0 0
Receivables 46.9 7.4 0.8 0.1 19.3 0.2 0.2 1.5 5.4 4 K 27.4 K 0.7
Inventory 0 1.3 0.7 2.1 1.5 1.1 3.8 1.2 0.1 1 2 0.128
Other Current Assets 13.7 51.5 54.2 34.0 10.2 32.0 24.1 22.0 5.2 10.6 1.4 0.6
Total Current Assets 207.6 255.4 415.5 398.2 120.5 231.1 230.2 198.8 295.1 54.1 1.6 3.9
PP&E 71.7 71.5 51.4 46.7 51.9 36.1 40.7 27.9 5.4 1.4 0.2 97.4 K
Intangible Assets 0.3 0.4 1.0 1.7 2.2 1.5 1.3 1.3 0.2 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 1.6 1.7 4.6 4.5 4.1 4.3 4.0 4.5 0 0 0
Other Long Term Assets 3.0 1.6 1.7 4.6 7.0 8.1 8.9 6.6 4.7 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 1 1 0
Total Assets 282.6 328.9 469.5 451.1 181.5 276.7 281.1 234.5 300.7 55.5 1.8 4.0
LIABILITIES
Accounts Payable 8.1 4.8 8.1 6.4 6.4 4.1 8.4 11.3 2.0 2.0 1.0 1.9
Short Term Debt 10.8 5.5 4.6 5.5 5.0 0 0 0 1 0 41.6 1.5
Other Current Liabilities 23.5 30.8 27.6 24.3 20.9 20.4 21.5 15.5 3.6 (4.6) 50.5 0.7
Total Current Liabilities 72.8 64.5 62.5 39.1 34.3 24.4 74.3 40.3 26.8 53.1 4.0 4.1
Long Term Debt 39.7 40.7 46.3 41.9 45.9 0 0 0 0 0 0 0
Deferred Tax Income (19.9) 0 0 0 0 1.4 2.2 0 0 0 0 0
Other Liabilities (18.4) (19.1) (22.5) (20.3) (22.4) 5.4 3.8 3.1 (12.2) 0 0 0
Total Liabilities 243.1 247.0 263.6 109.9 57.9 29.9 78.2 68.4 41.1 53.1 4.0 4.1
EQUITY
Common Stock 1.9 1.4 1.3 1.3 0.9 0.9 0.9 0.7 0.7 3.41 K 1.52 K 1.57 K
Retained Earnings (1 023.2) (909.3) (743.8) (585.8) (455.7) (318.5) (231.6) (161.5) (47.2) (32.3) (17.6) (9.7)
Other Accumulative Comprehensive Income/Loss (3.7) (0.9) (11.1) (10.0) (7.3) (9.8) (21.6) (14.2) 126.7 0.2 47.1 K 7.85 K
Total Equity 39.5 81.9 206.0 341.2 123.6 246.9 203.0 166.1 259.6 2.4 (2.2) (0.1)
Total Liabilities and Equity 282.6 328.9 469.5 451.1 181.5 276.7 281.1 234.5 300.7 55.5 1.8 4.0
SHARES OUTSTANDING
Common Shares Outstanding 201.1 161.2 155.8 142.5 105.0 97.4 87.9 70.8 35.8 424.7 424.7